Marketplace eNewsletter Bi-Monthly | Having trouble viewing this e-mail? Click here.
Pharmaceutical Technology/BioPharm Marketplace eNewsletter

Pharmaceutical Sciences, Manufacturing & Marketplace Report December 4, 2013


  From Cynthia Challener, PhD, Editor, Pharmaceutical Sciences, Manufacturing & Marketplace Report
In this issue, excipients for controlling release and a new application of melt-spray congeal technology from AAPS. Novartis cell-culture influenza vaccine-manufacturing facility recognized, and technology advances in maintaining the cold chain. Plus developments in biocatalysis and chemocatalysis for API synthesis, and analysis of recent legislation to strengthen the drug supply chain.
 
 

   
 
Solid, Semisolid, and Specialty Dosage Forms
Image Placeholder
Ion-Bogdan Dumitrescu/Getty Images

New Solid Dose Technologies Highlighted at 2013 AAPS Annual Meeting & Expo

Excipients for lowering formulation costs and improving lipid-based formulations and the use of melt-spray-congeal microsphere sachet technology for targeted controlled release attract attention at the 2013 American Association of Pharmaceutical Scientists Annual Meeting. Click Here to Read More

Join our Solid, Semisolid, and Specialty Dosage Forms Linked-In Community
Biological API Manufacturing
Image Placeholder
Maciej Frolow/Getty Images
Novartis’ US Influenza Cell-Culture Facility Recognized

For its use of innovative technology for the production of seasonal and pandemic influenza vaccines, the Novartis Holly Springs, North Carolina facility was the Overall Winner of the 2013 Facility of the Year Award issued by the International Society for Pharmaceutical Engineering (ISPE). Click Here to Read More

Join our Biological API Manufacturing Linked-In Community
 
Parenterals
Image Placeholder
Maria Toutoudaki/Getty Images
Maintaining and Verifying the Cold Chain

Tools and services provide thermal protection and prove cold-chain compliance. Click Here to Read More

Join our Parenterals Linked-In Community
 
Chemical API Manufacturing
Image Placeholder
Alfred Pasieka/Getty Images

Applying Catalysis to Optimize API Synthesis

Fine-chemical companies, contract manufacturers, and researchers advance chemocatalysis and biocatalysis. Click Here to Read More

Join our Chemical API Manufacturing Linked-In Community
 
Pharmaceutical Analysis
Image Placeholder
Adam Gault/Getty Images

Congress Revises Rules for Drug Compounding and Supply-Chain Security

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking. Click Here to Read More

Join our Pharmaceutical Analysis Linked-In Community
 
Other Recent Developments

Site-Specific Conjugation of Cytotoxic Cytolysins Could Lead to Highly Effective Antibody-Drug Conjugates
Recent collaboration offers more heterogeneous, stable antibody drug conjugates of synthetic tubulin-binding agents shown to rapidly trigger cancer cell death.

Overcoming Challenges in Fluorine-Based Chemistry
Fluorinated molecules are important as pharmaceutical compounds. Recent advances involve selective and late-stage insertion of fluorine into small molecules.

Careful Process Mapping Can Significantly Reduce Product Losses in Fill-Finish Operations
Changes in the working procedures and disposable fluid flow paths resulted in a measurable decrease in product waste in a low-volume, high-value fill-finish line.

FDA Seeks Metrics to Define Drug Quality
Manufacturing standards are considered key to preventing drug recalls and shortages.

Tablet-Sticking Solutions
Screening methods and predictive models address tenacious tablet-sticking problems.

 
The Pharmaceutical Sciences, Manufacturing & Marketplace Report is a biweekly newsletter of Pharmaceutical Technology and BioPharm International, and an exclusive feature of the new Pharmaceutical Technology/BioPharm International Marketplace, an online community focused on products and services for drug development and manufacturing. The Pharmaceutical Sciences, Manufacturing & Marketplace Report provides insight in five main communities: solid, semisolid, and specialty dosage forms; parenterals; chemical API manufacturing; biological API manufacturing; and pharmaceutical analysis.  
 
Image Placeholder

Perspectives from Cynthia Challener, PhD, editor of the Pharmaceutical Sciences, Manufacturing & Marketplace Report and industry members
Image Placeholder Marketplace Report Blog
Image Placeholder

 
| Subscribe | Send Feedback | Advertise With Us | Visit pharmabiomarketplace.com |